DE602005011800D1 - Identifizierung von eine zelluläre antwort modifizierenden verbindungen - Google Patents

Identifizierung von eine zelluläre antwort modifizierenden verbindungen

Info

Publication number
DE602005011800D1
DE602005011800D1 DE602005011800T DE602005011800T DE602005011800D1 DE 602005011800 D1 DE602005011800 D1 DE 602005011800D1 DE 602005011800 T DE602005011800 T DE 602005011800T DE 602005011800 T DE602005011800 T DE 602005011800T DE 602005011800 D1 DE602005011800 D1 DE 602005011800D1
Authority
DE
Germany
Prior art keywords
identification
cellular response
modifying compound
solid supports
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005011800T
Other languages
English (en)
Inventor
Grith Hagel
Ole Thastrup
Morten Meldal
Jens Chr Norrild
Morten Hentzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
2cureX ApS
Original Assignee
2cureX ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 2cureX ApS filed Critical 2cureX ApS
Publication of DE602005011800D1 publication Critical patent/DE602005011800D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
    • G01N2035/00099—Characterised by type of test elements
    • G01N2035/00158—Elements containing microarrays, i.e. "biochip"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005011800T 2004-05-25 2005-05-25 Identifizierung von eine zelluläre antwort modifizierenden verbindungen Active DE602005011800D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400822 2004-05-25
DKPA200400821 2004-05-25
PCT/DK2005/000347 WO2005116656A1 (en) 2004-05-25 2005-05-25 Identification of compounds modifying a cellular response

Publications (1)

Publication Number Publication Date
DE602005011800D1 true DE602005011800D1 (de) 2009-01-29

Family

ID=34968405

Family Applications (2)

Application Number Title Priority Date Filing Date
DE602005011800T Active DE602005011800D1 (de) 2004-05-25 2005-05-25 Identifizierung von eine zelluläre antwort modifizierenden verbindungen
DE602005015715T Active DE602005015715D1 (de) 2004-05-25 2005-05-25 Identifizierung von eine zelluläre antwort modifizierenden verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE602005015715T Active DE602005015715D1 (de) 2004-05-25 2005-05-25 Identifizierung von eine zelluläre antwort modifizierenden verbindungen

Country Status (8)

Country Link
US (3) US20090239755A1 (de)
EP (2) EP1761783B1 (de)
AT (2) ATE438102T1 (de)
AU (1) AU2005248453B2 (de)
CA (2) CA2568168C (de)
DE (2) DE602005011800D1 (de)
ES (1) ES2330538T3 (de)
WO (2) WO2005116656A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20060200A0 (fi) * 2005-04-20 2006-02-27 Glykos Finland Oy Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
AU2006254538A1 (en) * 2005-05-25 2006-12-07 2Curex Aps Compounds modifying apoptosis
US8318717B2 (en) 2005-05-25 2012-11-27 2Curex Compounds modifying apoptosis
WO2007009457A2 (en) * 2005-07-18 2007-01-25 2Curex Aps Identification of protein ligands modifying a cellular response
US8983581B2 (en) * 2008-05-27 2015-03-17 Massachusetts Institute Of Technology System and method for large field of view, single cell analysis
US9155471B2 (en) 2009-05-27 2015-10-13 Lumicell, Inc'. Methods and systems for spatially identifying abnormal cells
KR20120093151A (ko) * 2009-07-15 2012-08-22 에이전시 포 사이언스, 테크놀로지 앤드 리서치 개선된 바이오폴리머의 스크리닝
CN102648312B (zh) 2009-07-22 2014-03-05 新加坡科技研究局 同质量氨基酸和其它物质的区分
US9314304B2 (en) 2010-12-08 2016-04-19 Lumicell, Inc. Methods and system for image guided cell ablation with microscopic resolution
US9783841B2 (en) 2012-10-04 2017-10-10 The Board Of Trustees Of The Leland Stanford Junior University Detection of target nucleic acids in a cellular sample
WO2014152389A1 (en) 2013-03-14 2014-09-25 Lumicell, Inc. Imaging agent for detection of diseased cells
EP3027226A4 (de) * 2013-08-02 2016-07-27 Siemens Healthcare Diagnostics Zellbasierte steuerung und verfahren
AU2015283320B2 (en) * 2014-07-02 2019-10-03 2Curex Aps Identifying compounds modifying a cellular phenotype
CN105068468B (zh) * 2015-07-15 2020-02-04 杭州来昂电子有限公司 基于光线感应的数码管自动识别系统
CN111344406A (zh) * 2017-08-17 2020-06-26 株式会社香味醗酵 气味的定量方法、其所使用的细胞及该细胞的制造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293654A (en) * 1977-10-17 1981-10-06 Massachusetts Institute Of Technology Cell culture microcarriers
US4266032A (en) * 1979-08-10 1981-05-05 Monsanto Company Method of culturing microcarrier supported cells
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
AU2002226876A1 (en) * 2000-10-06 2002-04-15 Quantum Dot Corporation Cells having a spectral signature, and methods of preparation and use thereof
JP2004537712A (ja) * 2000-10-18 2004-12-16 バーチャル・アレイズ・インコーポレーテッド 多重細胞分析システム
WO2003038431A1 (en) * 2001-10-26 2003-05-08 The Regents Of The University Of California Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells
US7262269B2 (en) * 2001-10-26 2007-08-28 The Regents Of University Of California Method for screening combinational bead library; ligands for cancer cells
US6670142B2 (en) * 2001-10-26 2003-12-30 The Regents Of The University Of California Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells
AU2003287040A1 (en) * 2003-10-08 2005-05-26 The Regents Of The University Of California Screening combinatorial bead libraries for cancer ligands
US20050153321A1 (en) * 2003-12-30 2005-07-14 Saba James A. Libraries of multiple-ligand-conjugated nucleic acids

Also Published As

Publication number Publication date
WO2005116643A3 (en) 2006-03-23
AU2005248453A1 (en) 2005-12-08
EP1761783A2 (de) 2007-03-14
AU2005248453B2 (en) 2011-09-08
US20110319274A1 (en) 2011-12-29
EP1759212A1 (de) 2007-03-07
CA2609558C (en) 2013-12-24
WO2005116656A1 (en) 2005-12-08
US20130123140A1 (en) 2013-05-16
DE602005015715D1 (de) 2009-09-10
EP1761783B1 (de) 2009-07-29
CA2568168A1 (en) 2005-12-08
ATE438102T1 (de) 2009-08-15
CA2568168C (en) 2016-07-05
EP1759212B1 (de) 2008-12-17
US9150899B2 (en) 2015-10-06
CA2609558A1 (en) 2005-12-08
ATE418074T1 (de) 2009-01-15
ES2330538T3 (es) 2009-12-11
WO2005116643A2 (en) 2005-12-08
US20090239755A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
DE602005015715D1 (de) Identifizierung von eine zelluläre antwort modifizierenden verbindungen
US20230340458A1 (en) Methods and kits using nucleic acid encoding and/or label
WO2005028624A3 (en) Molecular scaffolds for kinase ligand development
ATE480643T1 (de) Homogener nachweis von analyten
ATE505489T1 (de) Tgf-beta-1-spezifische antikörper
ATE549414T1 (de) Verfahren zur isolierung von zellen
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
WO2004061084A8 (en) Modulation of protein functionalities
WO2001027624A3 (en) Compositions and methods for detecting protein modification and enzymatic activity
DK1421389T3 (da) Neurofibrilmarkører
WO2005019470A3 (en) Detecting and profiling molecular complexes
DE602006004196D1 (de) Verfahren zur Identifizierung von mit ZAP-70 wechselwirkenden Molekülen und zur ZAP-70-Reinigung
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
WO2007076339A3 (en) Isotopically labelled crosslinking agents for the analysis of protein interactions
ATE407703T1 (de) Verbindungen und kits zur herstellung von bildgebenden mitteln und bildgebungsverfahren
WO2002063271A3 (en) Activity based probe analysis
ATE404692T1 (de) Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen.
EA200701578A1 (ru) Способ конъюгирования молекул, содержащих аминотиол, к носителям
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
Wennemers Peptides as asymmetric catalysts and templates for the controlled formation of Ag nanoparticles
ATE478156T1 (de) Verfahren zur identifizierung von modulatoren der eoxin-bildung
Früh et al. Functional modification of fibronectin by N‐terminal FXIIIa‐mediated transamidation
DE602005018808D1 (de) Odifizierung der supercoil-topologie von nukleinsäuren sowie modulatoren
Field et al. Fluorophosphonate‐Based Degrader Identifies Degradable Serine Hydrolases by Quantitative Proteomics
WO2007009457A3 (en) Identification of protein ligands modifying a cellular response

Legal Events

Date Code Title Description
8364 No opposition during term of opposition